- RMTI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Rockwell Medical (RMTI) CORRESPCorrespondence with SEC
Filed: 20 Jul 22, 12:00am
Rockwell Medical, Inc.
30142 S. Wixom Road
Wixom, Michigan 48393
(248) 960-9009
July 20, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attn: | Joshua Gorsky |
Re: | Rockwell Medical, Inc. Registration Statement on Form S-3 Filed July 14, 2022 File No. 333-266135 |
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Rockwell Medical, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective time of the above referenced Registration Statement on Form S-3 filed by the Company be accelerated to 5:01 p.m., Eastern Standard Time, on July 22, 2022 or as soon thereafter as practicable.
Very truly yours, | ||
Rockwell Medical, Inc. | ||
By: | /s/ Russell Skibsted | |
Name: | Russell Skibsted | |
Title: | Chief Financial Officer |
cc: | Ryan A. Murr, Gibson, Dunn & Crutcher LLP |